Jayempi Evropska unija - slovenščina - EMA (European Medicines Agency)

jayempi

nova laboratories ireland limited - azathioprine - zavrnitev presadka - imunosupresivi - jayempi is indicated in combination with other immunosuppressive agents for the prophylaxis of transplant rejection in patients receiving allogenic kidney, liver, heart, lung or pancreas transplants. azathioprine is indicated in immunosuppressive regimens as an adjunct to immunosuppressive agents that form the mainstay of treatment (basis immunosuppression). jayempi is used as an immunosuppressant antimetabolite either alone or, more commonly, in combination with other agents (usually corticosteroids) and/ or procedures which influence the immune response. jayempi is indicated in patients who are intolerant to glucocorticosteroids or if the therapeutic response is inadequate despite treatment with high doses of glucocorticosteroids, in the following diseases:severe active rheumatoid arthritis (chronic polyarthritis) that cannot be kept under control by less toxic agents (disease-modifying anti-rheumatic -medicinal products – dmards)auto-immune hepatitis systemic lupus erythematosusdermatomyositispolyarteritis nodosapemphigus vulgaris and bullous pemphigoidbehçet’s diseaserefractory auto-immune haemolytic anaemia, caused by warm igg antibodieschronic refractory idiopathic thrombocytopenic purpurajayempi is used for the treatment of moderately severe to severe forms of chronic inflammatory bowel disease (ibd) (crohn’s disease or ulcerative colitis) in patients in whom glucocorticosteroid therapy is necessary, but where glucocorticosteroids are not tolerated, or in whom the disease is untreatable with other common means of first choice. it is also indicated in adult patients in relapsing multiple sclerosis, if an immunomodulatory therapy is indicated but beta interferon therapy is not possible, or a stable course has been achieved with previous treatment with azathioprine. 3jayempi is indicated for the treatment of generalised myasthenia gravis. depending on the severity of the disease, jayempi should be given in combination with glucocorticosteroids because of slow onset of action at the beginning of treatment and the glucocorticosteroid dose should be gradually reduced after several months of treatment.

Qaialdo Evropska unija - slovenščina - EMA (European Medicines Agency)

qaialdo

nova laboratories ireland limited - spironolakton - edema; heart failure; liver cirrhosis; ascites; nephrotic syndrome; hyperaldosteronism; essential hypertension - antihypertensives and diuretics in combination - in the management of refractory oedema associated with congestive cardiac failure; hepatic cirrhosis with ascites and oedema, malignant ascites, nephrotic syndrome, diagnosis and treatment of primary aldosteronism, essential hypertension. neonates, children and adolescents should only be treated under guidance of a paediatric specialist (see sections 5. 1 in 5.

Deksametazon Krka 20 mg tablete Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

deksametazon krka 20 mg tablete

krka, d.d., novo mesto - deksametazon - tableta - deksametazon 20 mg / 1 tableta - deksametazon

Deksametazon Krka 4 mg tablete Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

deksametazon krka 4 mg tablete

krka, d.d., novo mesto - deksametazon - tableta - deksametazon 4 mg / 1 tableta - deksametazon

Diflucan 10 mg/ml prašek za peroralno suspenzijo Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

diflucan 10 mg/ml prašek za peroralno suspenzijo

pfizer luxembourg sarl - flukonazol - prašek za peroralno suspenzijo - flukonazol 10 mg / 1 ml - flukonazol

Diflucan 40 mg/ml prašek za peroralno suspenzijo Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

diflucan 40 mg/ml prašek za peroralno suspenzijo

pfizer luxembourg sarl - flukonazol - prašek za peroralno suspenzijo - flukonazol 40 mg / 1 ml - flukonazol

Levodopa/karbidopa/entakapon Teva 100 mg/25 mg/200 mg filmsko obložene tablete Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

levodopa/karbidopa/entakapon teva 100 mg/25 mg/200 mg filmsko obložene tablete

teva pharma b.v. - karbidopa; levodopa; entakapon - filmsko obložena tableta - karbidopa 25 mg / 1 tableta  levodopa100 mg / 1 tableta  entakapon200 mg / 1 tableta; levodopa 100 mg / 1 tableta  entakapon200 mg / 1 tableta; entakapon 200 mg / 1 tableta - levodopa, zaviralec dekarboksilaze in zaviralec comt